Zenith Epigenetics

Developer of small molecule BET inhibitors for cancer and autoimmune disorders

placeCalgary, Alberta, Canada calendar_todayFounded 2013 groups16 employees language zenithepigenetics.com

Social engagement

Social engagement: 1.2K social following, 3 posts in the last 12 months — below the industry typical range.

Recent activity

14 Jul 2025
Milestone
regulatory
Coming soon